Filing Overview
Nuveen Churchill Direct Lending Corp. filed a Form 8-K reporting that two wholly owned subsidiaries, Nuveen Churchill BDC SPV II, LLC and Nuveen Churchill BDC SPV IV, LLC, entered into a first amendment to their amended and restated Loan and Servicing Agreement on November 21, 2023. The report was signed on November 27, 2023.
Material Financing Changes
- Reinvestment period: Extended from November 24, 2023 to November 24, 2024.
- Stated maturity: Extended from November 24, 2025 to November 24, 2026.
- Interest rate: Increased from either Base Rate plus 1.15% or Term SOFR plus 2.15% to either Base Rate plus 1.65% or Term SOFR plus 2.65%.
- Facility amount: Reduced from $300 million to $150 million upon a permitted securitization, with a possible increase to $250 million at the administrative agent’s sole discretion if requested by the borrowers.
- Unused commitment fee: A 0.50% annual fee applies from the third through the sixth month after the amendment date. Beginning after the sixth month, the fee is 0.50% if unused commitments are below 50% of total commitments and 1.00% if unused commitments are at least 50%.
- Extension-related fees: The borrowers will pay a $450,000 extension fee plus an annualized fee of 0.30% multiplied by $150 million, based on the time until a permitted securitization occurs.
Financial Metrics and Liquidity
The filing does not provide revenue, earnings, cash flow, asset values, leverage ratios, margins, or liquidity balances. It does establish or modify a borrowing facility and therefore creates or amends a direct financial obligation of the registrant through its subsidiaries.
Outlook, Risks, and Unusual Items
- The amendment extends financing availability but increases the applicable borrowing spreads and may increase the cost of unused commitments.
- The maximum facility may be reduced to $150 million following a permitted securitization, and any subsequent increase to $250 million is subject to the administrative agent’s sole discretion.
- The filing does not provide management guidance or commentary regarding expected portfolio performance, securitization timing, or the likelihood of exercising the potential facility increase.
- The filing states that its summary of the amendment is qualified in its entirety by the full agreement filed as Exhibit 10.1.
Key Facts to Verify
- Review Exhibit 10.1 for complete conditions, covenants, collateral requirements, events of default, and definitions.
- Verify whether and when a permitted securitization occurs and whether the facility is reduced to $150 million.
- Monitor actual borrowings, unused commitments, and the resulting interest and commitment-fee expense.
- Assess the impact of the higher borrowing spreads and the extended maturity on funding costs and leverage.
- Confirm whether the administrative agent approves any requested increase of the facility to $250 million.